MONASH UNIVERSITY A world-first discovery by researchers at Monash University and The University of Queensland could lead to faster and more effective treatments for chronic health complications, such as cardiovascular disease and cancer, with ‘fluorescent’ in vivo biosensors. The research team, led by Dr Simon Corrie from Monash University’s Department of Chemical Engineering and the ARC Centre of Excellence...
Category: <span>Prognostic</span>
Post
New study on the role of monocytes in sarcoidosis
The cause of inflammatory lung disease sarcoidosis is unknown. In a new study, researchers at Karolinska Institutet have investigated whether a type of immune cell called a monocyte could be a key player in sarcoidosis pathogenesis and explain why some patients develop the more severe and chronic disease than others. The study, which is published in The...
Post
A new study shows the relationship between surgery and Alzheimer’s disease
IOS PRESS IMAGE: UNIDAD DE DETERIORO COGNITIVO CREDIT: VALDECILLA Amsterdam, January 21, 2021 – A new study published in the Journal of Alzheimer’s Disease carried out by researchers at the Marqués de Valdecilla-IDIVAL University Hospital, in collaboration with researchers at the University of Bonn Medical Center, proposes that major surgery is a promoter or accelerator of Alzheimer’s disease (AD). The...
Post
Increased risk of Parkinson’s disease in patients with schizophrenia
UNIVERSITY OF TURKU A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The increased risk may be due to alterations in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia. The...
Post
Coronavirus Disease 2019 (COVID-19) Clinical Presentation
Updated: Jan 09, 2021 Author: David J Cennimo, MD, FAAP, FACP, AAHIVS; Chief Editor: Michael Stuart Bronze, MD Clinical Progression A retrospective, single-center study from Shanghai evaluated clinical progression of COVID-19 in 249 patients. The interval from symptom onset to hospitalization averaged 4 days (range, 2-7 days) among symptomatic patients. The vast majority (94.3%) of patients developed fever....
Post
Facebook claims its AI can predict four days in advance if a coronavirus patient’s condition will deteriorate
By STACY LIBERATORE Facebook claims to have designed software capable of predicting if a coronavirus patient’s health will deteriorate or will need oxygen just by scanning their chest X-rays. Working with New York University (NYU), the social media firm says the system can calculate such developments four days. Together they have built three machine-learning models to assist doctors...
Post
Biomarkers in fathers’ sperm linked to offspring autism
WASHINGTON STATE UNIVERSITY PULLMAN, Wash. – Biomarkers in human sperm have been identified that can indicate a propensity to father children with autism spectrum disorder. These biomarkers are epigenetic, meaning they involve changes to molecular factors that regulate genome activity such as gene expression independent of DNA sequence, and can be passed down to future...
Post
Initial severity of COVID-19 not associated with later respiratory complications
AMERICAN THORACIC SOCIETY IMAGE: INITIAL SEVERITY ILLNESS NOT ASSOCIATED WITH COVID-19 COMPLICATIONS POST-RECOVERY. CREDIT: ATS Jan. 8, 2021 – A new study published online in the Annals of the American Thoracic Societyexamines the recovery of lung function and overall wellness in individuals who had varying degrees of COVID-19 severity. Little is known about lung health following...
Post
In-utero exposures associated with increased risk of thyroid cancer
by University of Bergen Credit: Unsplash/CC0 Public Domain A recent study by prof. Tone Bjørge, University of Bergen, and her team shows that thyroid cancer is related to in-utero exposures. Thyroid cancer is diagnosed at a younger age than most other malignancies and the incidence is higher in women than men. “The only established modifiable risk factors for thyroid...
Post
New App could help monitoring the progressions of Parkinson’s disease
Parkinson’s Disease is an incurable neurodegenerative disease, one of the most common causes of dementia and disability in the later years of life. Parkinson’s disease affects millions of people in the world, but its progression is not always the same. Now scientists at UCL and Birkbeck, University of London have developed an app, which allows...